Assessing the cost-effectiveness of annual COVID-19 booster vaccination in South Korea using a transmission dynamic model.

ABSTRACT:

Introduction

We evaluated the cost-effectiveness of South Korea's planned annual coronavirus disease 2019 (COVID-19) booster campaign scheduled for October 2023.

Materials and methods

An age-structured mathematical model was used to analyze the public impacts and cost-effectiveness of vaccination across three vaccination strategies: uniform allocation and prioritizing those over 65 or those over 50 years old. We calculated the incremental cost per quality-adjusted life year (QALY) from both healthcare and societal perspectives. The maximum vaccine cost for cost-effectiveness was also identified.

Results

Our analysis highlights the cost-effectiveness of South Korea's annual COVID-19 vaccination program in mitigating health and economic impacts. The most cost-effective

SUBMITTER: Choi W 

PROVIDER: S-EPMC10701673 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature